Arrowhead Pharma (ARWR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -40,080 | -19,264 | -91,941 | -67,198 | -51,262 |
| Depreciation Amortization | 1,778 | 903 | 3,447 | 2,426 | 1,408 |
| Accounts receivable | -25 | -1,055 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 2,511 | 257 | 2,498 | 2,328 | 2,402 |
| Other Working Capital | -2,044 | -5,190 | 3,408 | -3,318 | -2,508 |
| Other Operating Activity | 1,965 | 3,201 | 16,881 | 12,074 | 9,390 |
| Operating Cash Flow | $-35,896 | $-21,148 | $-65,708 | $-53,687 | $-40,570 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 6,200 | 3,000 | 26,091 | 19,411 | 12,151 |
| PPE Investments | -501 | -407 | -1,970 | -1,135 | -852 |
| Net Acquisitions | N/A | N/A | -10,000 | -10,000 | -7,000 |
| Investing Cash Flow | $5,699 | $2,593 | $14,121 | $8,276 | $4,299 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | -214 | N/A | N/A |
| Debt Repayment | -108 | -54 | N/A | -160 | -107 |
| Common Stock Issued | 26 | N/A | 505 | 314 | 314 |
| Other Financing Activity | -634 | -441 | 0 | 0 | 0 |
| Financing Cash Flow | $-717 | $-495 | $291 | $154 | $207 |
| Beginning Cash Position | 81,214 | 81,214 | 132,511 | 132,511 | 132,511 |
| End Cash Position | 50,301 | 62,165 | 81,214 | 87,253 | 96,447 |
| Net Cash Flow | $-30,914 | $-19,049 | $-51,296 | $-45,258 | $-36,063 |
| Free Cash Flow | |||||
| Operating Cash Flow | -35,896 | -21,148 | -65,708 | -53,687 | -40,570 |
| Capital Expenditure | -501 | -407 | -1,971 | -1,136 | -852 |
| Free Cash Flow | -36,397 | -21,555 | -67,678 | -54,823 | -41,422 |